A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i> -Mutated Myeloid MalignanciesCurtis A. Lachowiez, Courtney D. DiNardo, Rebecca S. Tidwell et al.|Blood Cancer Discovery|2023Cited by 122
Clonal evolution of hematopoietic stem cells after autologous stem cell transplantationHidetaka Uryu, Koichi Takahashi, Koichi Saeki et al.|Nature Genetics|2025Cited by 10
Clonal evolution of hematopoietic stem cells after cancer chemotherapyHidetaka Uryu, Koichi Takahashi, Koichi Saeki et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 6
SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cellsLinda Zhang, Margaret A. Goodell, Étienne De Braekeleer et al.|eLife|2023Cited by 1
Author Correction: Clonal evolution of hematopoietic stem cells after autologous stem cell transplantationHidetaka Uryu, Koichi Takahashi, Koichi Saeki et al.|Nature Genetics|2025Cited by 1